Cell and Gene Regulatory
-
Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
10/12/2026
At Meeting on the Mesa 2026, industry leaders discussed what it will take to move autoimmune CAR T beyond promising clinical results.
-
From The Mass Spec Continuum To AI-Enabled Developability Insights
10/9/2026
Growing modality heterogeneity strains assay-by-assay workflows. Mass spectrometry offers a way to track molecules across development, but its value depends on how the resulting data is handled.
-
Method Evaluation Guidance For Transferring A Process
10/9/2026
Moving a cell counting method between analyzers in a lab requires evidence of comparability. A structured study of suspension and adherent models tests precision and linearity against defined criteria.
-
How Phase I Trial Ethics Are Changing For Sponsors
10/8/2026
As early efficacy becomes possible in Phase I studies, hope for benefit must be weighed against limited knowledge, reshaping consent language, risk-benefit review, and protocol design for sponsors and IRBs.
-
SKyvec™ Lenti For In Vivo Applications
10/7/2026
When lentiviral vector moves from ex vivo intermediate to in vivo final drug product, purity, potency, and consistency expectations rise, and downstream capture performance becomes a central constraint.
-
Crude Peptide Purification Optimization For Scalable Manufacturing
10/7/2026
Transitioning lentiviral vectors to final drug product raises quality demands. A simplified membrane-based capture step minimizes downstream losses that can constrain systemic dosing.
-
Complete Response Letters For CGTs Share This Common Theme
10/7/2026
One expert’s analysis found CMC-related concerns in about 75% of complete response letters. He outlines a path to stronger CMC readiness for cell and gene therapies.
-
Building A Science- And Risk-Based Bio-Decontamination Strategy
10/5/2026
Annex 1 has made bio-decontamination central to sterility assurance, with isolator and barrier cycles now expected to be designed, justified, and reviewed across their lifecycle.
-
Comparative Evaluation Of NHP And VHP For Isolator Decontamination
10/5/2026
Comparative evaluation reveals how optimizing hydrogen peroxide cycle parameters improves pharmaceutical isolator bio-decontamination efficiency while maintaining Annex 1 sterility compliance.
-
Harness An Adept IRB's Expertise To Streamline Study Design
10/2/2026
An Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.